Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology
Sponsor: Y. Michael Shim, MD
Summary
A two-center, longitudinal assessment of 40 electronic cigarette users and 40 healthy controls at the initial visit and a follow-up visit 12 months later. This study will determine the impact of electronic cigarette use on pulmonary gas exchange capacity and then corroborate the Hyperpolarized Xenon MRI (HXeMRI) results with the cardiopulmonary stress test at the initial visit and a follow-up visit 12 months later.
Official title: Dissolved Phase Hyperpolarized Xenon-129 MRI: a Novel Biomarker to Quantify Pulmonary Pathology in Healthy Participants and E-cigarette Users
Key Details
Gender
All
Age Range
18 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-12-19
Completion Date
2032-12-31
Last Updated
2026-03-17
Healthy Volunteers
Yes
Conditions
Interventions
Hyperpolarized xenon 129
Determine the impact of e-cigarette use on pulmonary gas exchange capacity in interstitial tissues and capillaries using hyperpolarized xenon-129 MRI.
Cardiopulmonary Stress Test
Exercise stress test to evaluate cardiac and pulmonary fitness.
Pulmonary Function Test
Standard clinic pulmonary function test to evaluate lung function
Chest CT
Clinical standard chest computer tomography to evaluate any lung tissue scars or air movement.
Locations (2)
Duke University
Durham, North Carolina, United States
University of Virginia
Charlottesville, Virginia, United States